Target intelligence / Profile preview

Peripheral nerve tissue

Molecular classification
Other
01

Overview

Peripheral nerve tissue refers to the tissue of the peripheral nervous system, composed primarily of myelinated and unmyelinated axons, Schwann cells, satellite glial cells, and specialized connective tissue layers known as endoneurium, perineurium, and epineurium[3][7]. These tissues provide sensory and motor innervation to the body outside the brain and spinal cord. Schwann cells produce the myelin sheath and extracellular matrix, supporting rapid signal transduction and nerve regeneration[6][5]. Peripheral nerves play crucial roles in transmitting signals between the central nervous system and peripheral organs, and are involved in injury repair and modulation of neuroinflammatory responses, but the tissue itself is not a canonical molecular target for drugs or biologics[1][4][3]. Context and Supporting Details: - Peripheral nerve tissue consists of mixed cellular and extracellular components, primarily categorized by structure rather than a discrete molecular identity[3][7]. - The main cell types are Schwann cells (myelinating and non-myelinating), fibroblasts, macrophages, vascular cells, and some immune cells[4][6]. - Its biological functions include conduction of action potentials, physical support for axons, repair after injury, and participation in local immune responses[5][6]. - It is not listed as a therapeutic target in standard pharmacological or molecular target lists; rather, it is the anatomical substrate for nerve injury, regeneration, or neuropathy therapy targets (such as sodium channels, neurotrophic receptors, etc.). - Mischaracterizing tissue structures as molecular targets can complicate target-based drug development. For drug targeting, one would need to specify individual molecular components (e.g., sodium channel Nav1.7, Schwann cell myelin protein, etc.) rather than the whole tissue. Summary: Peripheral nerve tissue is an anatomical and histological entity, not a specific molecular therapeutic target; individual molecular targets must be specified for structured pharmacological applications[1][3][6].

Other names
Peripheral nervesPNS tissuePeripheral nervous tissue
02

Biological functions

Signal transductionNeural conductionAxonal regenerationCell supportTissue repair
03

Disease associations

Neurodegenerative diseaseNeuropathyInflammationPeripheral nerve injury
04

Safety considerations

Not a specific molecular target, so safety concerns are contextual (e.g., risk of nerve injury in local anesthesia)

Beyond the preview

Go deeper on Peripheral nerve tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peripheral nerve tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call